Please login to the form below

Not currently logged in
Email:
Password:

Inclisiran

This page shows the latest Inclisiran news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Leqvio shows sustained efficacy and safety for cardiac patients

Novartis’ Leqvio shows sustained efficacy and safety for cardiac patients

Low-density lipoprotein cholesterol level reduction was sustained over four years. Novartis has announced new long-term Leqvio (inclisiran) data, showing sustained efficacy and safety over a four-year period in

Latest news

More from news
Approximately 10 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...